Articoli di riviste sul tema "Acbp / dbi"

Eukaryotic cells release the phylogenetically ancient protein acyl coenzyme A binding protein (ACBP, which in humans is encoded by the gene DBI, diazepam binding inhibitor) upon nutrient deprivation. Accordingly, mice that are starved for one to two days and humans that undergo voluntary fasting for one to three weeks manifest an increase in the plasma concentration of ACBP/DBI. Paradoxically, ACBP/DBI levels also increase in obese mice and humans. Since ACBP/DBI stimulates appetite, this latter finding may explain why obesity constitutes a self-perpetuating state. Here, we present a theoretical framework to embed these findings in the mechanisms of weight control, as well as a bioinformatics analysis showing that, irrespective of the human cell or tissue type, one single isoform of ACBP/DBI (ACBP1) is preponderant (~90% of all DBI transcripts, with the sole exception of the testis, where it is ~70%). Based on our knowledge, we conclude that ACBP1 is subjected to a biphasic transcriptional and post-transcriptional regulation, explaining why obesity and fasting both are associated with increased circulating ACBP1 protein levels.

Peripheral benzodiazepine (BDZ) receptor (PBR) and diazepam-binding inhibitor/acyl-CoA-binding protein (DBI/ACBP) characterized as a ligand at central BDZ receptors, at PBR with involvement in the regulation of steroidogenesis, and as an intracellular acyl-CoA transporter, are both known to interact with BDZ in adult systems. We investigated their expression after prenatal exposure to BDZ. Diazepam (1.25 mg/kg per day s.c.) was administered to time-pregnant Long Evans rats from gestational day (GD) 14 to 20. Expression of mRNAs encoding for PBR and for DBI/ACBP was studied in the same animals with (33)P-labeled 60 mer oligonucleotides (oligos) by in situ hybridization at GD20, and with (32)P-labeled oligos by Northern blot in steroidogenic and immune organs at postnatal day (PN) 14 and in adult offspring. Prenatal diazepam increased DBI/ACBP mRNA expression in male fetal adrenal and in fetal and PN14 testis. Thymus exhibited increased DBI/ACBP mRNA in male fetuses and in adult female offspring, and reduced organ weight at PN14 in both sexes. In female spleen, an increase in DBI/ACBP mRNA and a decrease in PBR mRNA was seen at PN14. Apart from the finding in spleen, no drug-induced changes in PBR mRNA were observed. The effects of prenatal diazepam were superimposed on treatment-independent sex differences in DBI/ACBP mRNA and PBR mRNA expression. Our data indicate that expression of DBI/ACBP mRNA in steroidogenic and immune organs can be affected by exposure to BDZ during ontogeny, while PBR mRNA expression appears to be less sensitive. They further reveal marked sex differences in the developmental patterns of the two proteins during pre- and postpubertal ontogeny.

Östenson C-G, Ahrén B, Karlsson S, Knudsen J, Efendic S. Inhibition by rat diazepam-binding inhibitor/ acyl-CoA-binding protein of glucose-induced insulin secretion in the rat. Eur J Endocrinol 1994;131:201–4. ISSN 0804–4643 Diazepam-binding inhibitor (DBI) has been localized immunohistochemically in many organs. In porcine and rat pancreas, DBI is present in non-B-cells of the pancreatic islets. Porcine peptide also has been shown to suppress insulin secretion from rat pancreas in vitro. Recently, acyl-CoA-binding protein (ACBP) was isolated from rat liver and shown to be identical structurally to DBI isolated from rat brain. Using this rat DBI/ACBP, we have studied its effects on glucose-stimulated insulin secretion in the rat, both in vivo and in isolated pancreatic islets. Infusion iv of rDBI/ACBP (25 pmol/min) during glucose stimulation induced a moderate and transient reduction of plasma insulin levels. Moreover, rDBI/ACBP suppressed insulin release from batch-incubated isolated islets, stimulated by 16.7 mmol/l glucose, by 24% at 10 nmol/l (p < 0.05) and by 40% at 100 nmol/l (p < 0.01). The peptide (100 nmol/l) also inhibited the insulin response to glucose (16.7 mmol/l) from perifused rat islets by 31% (p < 0.05), mainly by affecting the acute-phase response. Finally, incubation of isolated islets in the presence of rDBI/ACBP antiserum (diluted 1:100 and 1:300) augmented the insulin response to 16.7 mmol/l glucose (p < 0.05 or even less). We conclude that rDBI/ACBP, administered iv or added to the incubation media, suppresses insulin secretion in the rat but that the effect is moderate despite the high concentration used. It is therefore unlikely that the peptide modulates islet hormone release, acting as a classical hormone via the circulation. However, the occurrence of DBI/ACBP in the islets and the enhancing effect by the rDBI/ACBP antibodies on glucose-stimulated insulin release suggest that the peptide is a local modulator of insulin secretion. C-G Östenson, Department of Endocrinology, Karolinska Hospital, S-171 76 Stockholm, Sweden

Astrocytes via their foot processes (ACfp) are specialized connecting cells, and they structurally connect the neurovascular unit (NVU) mural cells to neurons. Astrocytes provide homeostatic mechanisms for structural connections and provide communication between the NVU and regional neurons for functional hyperemia in regions of increased neuronal activity (neurovascular coupling). Previously, our group has demonstrated a detachment, separation, and retraction of ACfp in diabetic db/db females (DBC). It was hypothesized that a loss of adherent ACfp/NVU could result in the known impaired cognition in DBC. Additionally hypothesized was that empagliflozin treatment could protect DBC ACfp/NVU remodeling. This study demonstrates a significant loss of ACfp/NVU numbers in DBC and a protection of this loss by empagliflozin treatment (DBE). The number of intact ACfp/NVU was 6.45 ± 1.1 in control heterozygous (CKC) vs. 1.88 ± 0.72 in DBC (p < 0.05) and 5.86 ± 0.88 in DBE vs. DBC (p < 0.05) by visually hand-counting the capillary NVUs (22 in CKC, 25 in DBC, and 22 in DBE). These findings suggest that empagliflozin provides neuroprotection via the prevention of ACfp separation in DBE as compared to diabetic DBC. Furthermore, a loss of ACfp/NVU numbers in DBC may correspond with a negative modulation of informational processing, and the protection of ACfp/NVU numbers could provide a protective modulation in DBE models.

AbstractThis paper focuses on evolving an absorptive capacity (ACAP) assessment tool designed to help firms understand their ACAP maturity in processing external knowledge. ACAP maturity is evaluated based on a firm's capacity and willingness to do relevant ACAP practices. Although an earlier version of the ACAP tool was able to evaluate maturity and highlight immature practice, it could not determine how critical these practices were for improvement action. Thus, a means of eliciting the importance of practices and aggregating it with their ACAP maturity evaluations is needed. This paper provides summaries of the subjective weight elicitation methods and aggregation techniques which were identified from the domain of multi-criteria decision making. Criteria for comparing these methods are defined and analyzed to determine the most appropriate methods for the current application. The SRF method for subjective weight elicitation, aggregated with the maturity evaluations through weight sum models, is deemed the most appropriate for the current application. During testing with users, the SRF procedure was found to suffer from various usability concerns which will be investigated in future work.

Abstract Recent results of epidemiological studies indicate smoking as an environmental risk factor for development of rheumatoid arthritis (RA). The aim of this study was to evaluate the role of smoking and nicotine in the pathogenesis of arthritis using an animal model. DBA/1 mice were exposed to cigarette smoke for 16 weeks prior to immunization with collagen type II (CII) and through the whole course of experiment. In a separate experiment DBA/1 mice were subjected to nicotine in drinking water from the day of immunization with CII until the end of experiment. Severity of arthritis was evaluated clinically and morphologically and compared to control mice. Levels of specific anti-CII antibodies as well as of autoantibodies (aCCP and RF) and cytokines were evaluated. Clinical evaluation of arthritis showed a delayed onset of arthritis in smoking mice as compared to non-smoking (p&lt;0.05). Histological index and weight changes were comparable between both groups, however smoking mice were gaining weight faster than non-smoking (p&lt;0.05). Additionally, smoking mice had decreased ability to produce antibodies (aCCP and anti-CII) as compared to non-smoking (p&lt;0.05). Similar results were obtained in the mice exposed to nicotine. Nicotine had a direct anti-inflammatory effect diminishing cytokine production by stimulated spleenocytes in vitro. Neither smoking nor nicotine exposure aggravates development of CII-induced arthritis in mouse model.

This study is aimed to investigate and compare the physicochemical and sensory quality parameters which are associated with the freshness of the developed Custard apple juice milk beverage (CAJMB) subjected to cold plasma (CP)technology. The developed beverage was subjected to CP generated from two different configurations of Dielectric Barrier Discharge plasma (DBD) viz., High Voltage Atmospheric Cold Barrier Discharge plasma system (HV ACBD plasma system)and High Voltage Cold Barrier Discharge (HVCBD) Plasma torch/Gun using Argon gas. The treatments were performed for different processing times (2 & 3 min) at an applied voltage gradient of 35 kV and 30 kV respectively. The treatments did not have any potential change in the sensorial quality attributes evaluated immediately after processing compared to untreated control sample. However, a noteworthy difference was observed in pH and titratable acidity after processing, directly proportional to increase in treatment conditions concerning voltage and processing time. The pH and acidity at defined intervals during storage showed a slow rate of reduction as compared to the control. In the control sample levels of pH and acidity reached to an unacceptable range in 3 to 5 days of storage, due to the formation of lactic acid by subsequent microbial growth. Whereas, CP treated sample using HV ACBD plasma system at35kV for 3min exhibited promising results among other treatments and remained stable at refrigerated condition, with pH and acidity levels within the expected acceptable range for 9 to 10 days of storage.

Dakwah adalah upaya internalisasi, transmisi informasi dan difusi nilai-nilai Islam dari dai kepada mad’uw dengan memperimbangkan beragam aspek dari mad’uw, termasuk aspek budaya. Takmir Masjid Assalafiyah Kedung Asem, Kelurahan Kedung Baruk, Surabaya melaksanakan dakwah kultural dengan memasukkan nilai-nilai Islam pada acara tradisi Jawa selamatan desa. Kegiatan tersebut berhasil menghadirkan jemaah kurang lebih 3000 orang meskipun dilaksanakan di lingkungan perkotaan. Keberhasilan kegiatan dakwah kultural tersebut dapat menjadi pelajaran bagi masjid atau lembaga dakwah lainnya dalam pelaksanaan kegiataan dakwah kultural di masyarakat. Tulisan ini mendeskripsikan dakwah kultural dalam kegiatan selamatan desa yang diadakan takmir Masjid Assalafiyah. Dipandu oleh konsep dakwah kultural dari Acep Aripudin dan M. Sulthon. Tulisan ini menggunakan metode penelitian kualitatif dengan teknik analisis transkip hasil wawancara, reduksi data, analisis, interpretasi data dan triangulasi. Data diperoleh dari wawancara takmir, dokumentasi, dan observasi. Hasilnya dakwah kultural yang dilaksanakan melalui kegiatan selamatan desa merupakan akomodasi antara dua budaya yg berbeda, yaitu takmir Masjid Assalafiyah yang membawa nilai-nilai budaya Islam dan masyarakat Kedung Asem, yang kini didominasi warga pendatang dengan budaya Jawa Matraman. Bentuk interaksi yang terjadi secara umum bersifat akulturasi. Takmir Masjid berhasil memasukkan kegiatan yang bernuansa lebih Islami dalam tradisi selamatan desa Kedung Asem. Kegiatan dakwah kultural dapat digolongkan sebagai dakwah ummah dan terlaksana secara bottom-up.

Abstract. We modeled the global atmospheric dispersion and deposition of radionuclides released from the Fukushima Dai-ichi nuclear power plant accident. The EMAC atmospheric chemistry – general circulation model was used, with circulation dynamics nudged towards ERA-Interim reanalysis data. We applied a resolution of approximately 0.5 degrees in latitude and longitude (T255). The model accounts for emissions and transport of the radioactive isotopes 131I and 137Cs, and removal processes through precipitation, particle sedimentation and dry deposition. In addition, we simulated the release of 133Xe, a noble gas that can be regarded as a passive transport tracer of contaminated air. The source terms are based on Chino et al. (2011) and Stohl et al. (2012); especially the emission estimates of 131I are associated with a high degree of uncertainty. The calculated concentrations have been compared to station observations by the Comprehensive Nuclear-Test-Ban Treaty Organisation (CTBTO). We calculated that about 80% of the radioactivity from Fukushima which was released to the atmosphere deposited into the Pacific Ocean. In Japan a large inhabited land area was contaminated by more than 40 kBq m-2. We also estimated the inhalation and 50-year dose by 137Cs, 134Cs and 131I to which the people in Japan are exposed.

Abstract. The atmospheric transport and ground deposition of radioactive isotopes 131I and 137Cs during and after the Fukushima Dai-ichi Nuclear Power Plant (FDNPP) accident (March 2011) are investigated using the Weather Research and Forecasting-Chemistry (WRF-Chem) model. The aim is to assess the skill of WRF in simulating these processes and the sensitivity of the model's performance to various parameterizations of unresolved physics. The WRF-Chem model is first upgraded by implementing a radioactive decay term into the advection–diffusion solver and adding three parameterizations for dry deposition and two parameterizations for wet deposition. Different microphysics and horizontal turbulent diffusion schemes are then tested for their ability to reproduce observed meteorological conditions. Subsequently, the influence of emission characteristics (including the emission rate, the gas partitioning of 131I and the size distribution of 137Cs) on the simulated transport and deposition is examined. The results show that the model can predict the wind fields and rainfall realistically and that the ground deposition of the radionuclides can also be captured reasonably well. The modeled precipitation is largely influenced by the microphysics schemes, while the influence of the horizontal diffusion schemes on the wind fields is subtle. However, the ground deposition of radionuclides is sensitive to both horizontal diffusion schemes and microphysical schemes. Wet deposition dominated over dry deposition at most of the observation stations, but not at all locations in the simulated domain. To assess the sensitivity of the total daily deposition to all of the model physics and inputs, the averaged absolute value of the difference (AAD) is proposed. Based on AAD, the total deposition is mainly influenced by the emission rate for both 131I and 137Cs; while it is not sensitive to the dry deposition parameterizations since the dry deposition is just a minor fraction of the total deposition. Moreover, for 131I, the deposition is moderately sensitive (AAD between 10 and 40% between different runs) to the microphysics schemes, the horizontal diffusion schemes, gas-partitioning and wet deposition parameterizations. For 137Cs, the deposition is very sensitive (AAD exceeding 40% between different runs) to the microphysics schemes and wet deposition parameterizations, but moderately sensitive to the horizontal diffusion schemes and the size distribution.

Abstract. An increased trend in aerosol concentration has been observed in the Himalayas in recent years, but the understanding of the chemical composition and sources of aerosol remains poorly understood. In this study, molecular chemical composition of water-soluble organic matter (WSOM) from two filter samples collected during two high aerosol loading periods (denoted as P1 and P2) at a high-altitude station (Qomolangma Station, QOMS; 4276 m a.s.l.) in the northern Himalayas was identified using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry (ESI-FTICR MS). More than 4000 molecular formulas were identified in each filter sample which were classified into two compound groups (CHO and CHON) based on their elemental composition, with both accounting for nearly equal contributions in number (45 %–55 %). The relative abundance weighted mole ratio of O∕Cw for P1 and P2 was 0.43 and 0.39, respectively, and the weighted double bond equivalents (DBEw), an index for the saturation of organic molecules, were 7.12 and 7.87, respectively. Although the O∕Cw mole ratio was comparable for CHO and CHON compounds, the DBEw was significantly higher in CHON compounds than CHO compounds. More than 50 % molecular formulas in the Van Krevelen (VK) diagram (H∕C vs. O∕C) were located in 1–1.5 (H∕C) and 0.2–0.6 (O∕C) regions, suggesting potential lignin-like compounds. The distributions of CHO and CHON compounds in the VK diagram, DBE vs. number of C atoms, and other diagnostic diagrams showed high similarities among each other, suggesting their similar source and/or atmospheric processes. Many formulas formed from biogenic volatile organic compounds (e.g., ozonolysis of α-pinene products) and biomass-burning-emitted compounds (e.g., phenolic compounds) were found in the WSOM, suggesting the important contribution of these two sources in the Himalayas. The high DBE and high fraction of nitrogen-containing aerosol can potentially impact aerosol light absorption in this remote region. Further comprehensive study is needed due to the complexity of organic aerosol and limited molecular number identified in this study.

Abstract. On 11 March 2011, an earthquake occurred about 130 km off the Pacific coast of Japan's main island Honshu, followed by a large tsunami. The resulting loss of electric power at the Fukushima Dai-ichi nuclear power plant developed into a disaster causing massive release of radioactivity into the atmosphere. In this study, we determine the emissions into the atmosphere of two isotopes, the noble gas xenon-133 (133Xe) and the aerosol-bound caesium-137 (137Cs), which have very different release characteristics as well as behavior in the atmosphere. To determine radionuclide emissions as a function of height and time until 20 April, we made a first guess of release rates based on fuel inventories and documented accident events at the site. This first guess was subsequently improved by inverse modeling, which combined it with the results of an atmospheric transport model, FLEXPART, and measurement data from several dozen stations in Japan, North America and other regions. We used both atmospheric activity concentration measurements as well as, for 137Cs, measurements of bulk deposition. Regarding 133Xe, we find a total release of 15.3 (uncertainty range 12.2–18.3) EBq, which is more than twice as high as the total release from Chernobyl and likely the largest radioactive noble gas release in history. The entire noble gas inventory of reactor units 1–3 was set free into the atmosphere between 11 and 15 March 2011. In fact, our release estimate is higher than the entire estimated 133Xe inventory of the Fukushima Dai-ichi nuclear power plant, which we explain with the decay of iodine-133 (half-life of 20.8 h) into 133Xe. There is strong evidence that the 133Xe release started before the first active venting was made, possibly indicating structural damage to reactor components and/or leaks due to overpressure which would have allowed early release of noble gases. For 137Cs, the inversion results give a total emission of 36.6 (20.1–53.1) PBq, or about 43% of the estimated Chernobyl emission. Our results indicate that 137Cs emissions peaked on 14–15 March but were generally high from 12 until 19 March, when they suddenly dropped by orders of magnitude at the time when spraying of water on the spent-fuel pool of unit 4 started. This indicates that emissions may not have originated only from the damaged reactor cores, but also from the spent-fuel pool of unit 4. This would also confirm that the spraying was an effective countermeasure. We explore the main dispersion and deposition patterns of the radioactive cloud, both regionally for Japan as well as for the entire Northern Hemisphere. While at first sight it seemed fortunate that westerly winds prevailed most of the time during the accident, a different picture emerges from our detailed analysis. Exactly during and following the period of the strongest 137Cs emissions on 14 and 15 March as well as after another period with strong emissions on 19 March, the radioactive plume was advected over Eastern Honshu Island, where precipitation deposited a large fraction of 137Cs on land surfaces. Radioactive clouds reached North America on 15 March and Europe on 22 March. By middle of April, 133Xe was fairly uniformly distributed in the middle latitudes of the entire Northern Hemisphere and was for the first time also measured in the Southern Hemisphere (Darwin station, Australia). In general, simulated and observed concentrations of 133Xe and 137Cs both at Japanese as well as at remote sites were in good quantitative agreement. Altogether, we estimate that 6.4 PBq of 137Cs, or 18% of the total fallout until 20 April, were deposited over Japanese land areas, while most of the rest fell over the North Pacific Ocean. Only 0.7 PBq, or 1.9% of the total fallout were deposited on land areas other than Japan.

Abstract. Levoglucosan (LG) is a widely employed tracer for biomass burning (BB). Recent studies have shown that LG can react rapidly with hydroxyl (OH) radicals in the aqueous phase despite many mass balance receptor models assuming it to be inert during atmospheric transport. In the current study, aqueous-phase photooxidation of LG by OH radicals was performed in the laboratory. The reaction kinetics and products were monitored by aerosol time-of-flight chemical ionization mass spectrometry (Aerosol ToF-CIMS). Approximately 50 reaction products were detected by the Aerosol ToF-CIMS during the photooxidation experiments, representing one of the most detailed product studies yet performed. By following the evolution of mass defects of product peaks, unique trends of adding oxygen (+O) and removing hydrogen (−2H) were observed among the products detected, providing useful information for determining potential reaction mechanisms and sequences. Additionally, bond-scission reactions take place, leading to reaction intermediates with lower carbon numbers. We introduce a data analysis framework where the average oxidation state (OSc) is plotted against a novel molecular property: double-bond-equivalence-to-carbon ratio (DBE/#C). The trajectory of LG photooxidation on this plot suggests formation of polycarbonyl intermediates and their subsequent conversion to carboxylic acids as a general reaction trend. We also determined the rate constant of LG with OH radicals at room temperature to be 1.08 ± 0.16 × 109 M−1 s−1. By coupling an aerosol mass spectrometer (AMS) to the system, we observed a rapid decay of the mass fraction of organic signals at mass-to-charge ratio 60 (f60), corresponding closely to the LG decay monitored by the Aerosol ToF-CIMS. The trajectory of LG photooxidation on a f44–f60 correlation plot matched closely to literature field measurement data. This implies that aqueous-phase photooxidation might be partially contributing to aging of BB particles in the ambient atmosphere.

Abstract. Brominated flame retardants (BFRs) that are gradually being phased out are being replaced by emerging BFRs. Here, we report the concentration of the α- and β-isomers of 1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane (TBECH; also known as DBE-DBCH) in over 300 air, water, and precipitation samples collected between 2019 and 2022 using active air and deposition sampling as well as networks of passive air and water samplers. The sampling region includes Canada's most populated cities and areas along the St. Lawrence River and Estuary, Quebec, as well as around the Salish Sea, British Columbia. TBECH was detected in over 60 % of air samples at levels comparable to those of 2,2′,4,4′-tetrabromodiphenyl ether (BDE-47). Concentrations of TBECH and BDE-47 were typically higher in urban areas, with stronger correlations with population density during warmer deployments. Uniform α- / β-TBECH ratios across space, time, and environmental media indicate the highly similar atmospheric fate of the two isomers. Although TBECH air concentrations were strongly related to temperature in urban Toronto and a remote site on the east coast, the lack of such dependence at a remote site on the west coast can be explained by the small seasonal temperature range and summertime air mass transport from the Pacific Ocean. Despite there being no evidence that TBECH has been produced, or imported for use, in Canada, it is now one of the most abundant gaseous BFRs in the Canadian atmosphere. The recorded spatial and temporal variability of TBECH suggest that its emissions are not constrained to specific locations but are generally tied to the presence of humans. The most likely explanation for its environmental occurrence in Canada is the release from imported consumer products containing TBECH. Chiral analysis suggests that despite its urban origin, at least some fraction of TBECH has experienced enantioselective processing, i.e., has volatilized from reservoirs where it has undergone microbial transformations. Microbial processes in urban soils and in marine waters may have divergent enantioselectivity.

Abstract. Caesium-137 (137Cs) and iodine-131 (131I) are radionuclides of particular concern during nuclear accidents, because they are emitted in large amounts and are of significant health impact. 137Cs and 131I attach to the ambient accumulation-mode (AM) aerosols and share their fate as the aerosols are removed from the atmosphere by scavenging within clouds, precipitation and dry deposition. Here, we estimate their removal times from the atmosphere using a unique high-precision global measurement data set collected over several months after the accident at the Fukushima Dai-ichi nuclear power plant in March 2011. The noble gas xenon-133 (133Xe), also released during the accident, served as a passive tracer of air mass transport for determining the removal times of 137Cs and 131I via the decrease in the measured ratios 137Cs/133Xe and 131I/133Xe over time. After correction for radioactive decay, the 137Cs/133Xe ratios reflect the removal of aerosols by wet and dry deposition, whereas the 131I/133Xe ratios are also influenced by aerosol production from gaseous 131I. We find removal times for 137Cs of 10.0–13.9 days and for 131I of 17.1–24.2 days during April and May 2011. The removal time of 131I is longer due to the aerosol production from gaseous 131I, thus the removal time for 137Cs serves as a better estimate for aerosol lifetime. The removal time of 131I is of interest for semi-volatile species. We discuss possible caveats (e.g. late emissions, resuspension) that can affect the results, and compare the 137Cs removal times with observation-based and modeled aerosol lifetimes. Our 137Cs removal time of 10.0–13.9 days should be representative of a "background" AM aerosol well mixed in the extratropical Northern Hemisphere troposphere. It is expected that the lifetime of this vertically mixed background aerosol is longer than the lifetime of fresh AM aerosols directly emitted from surface sources. However, the substantial difference to the mean lifetimes of AM aerosols obtained from aerosol models, typically in the range of 3–7 days, warrants further research on the cause of this discrepancy. Too short modeled AM aerosol lifetimes would have serious implications for air quality and climate model predictions.

Abstract. Aerosols have important impacts on air quality and climate, but the processes affecting their removal from the atmosphere are not fully understood and are poorly constrained by observations. This makes modelled aerosol lifetimes uncertain. In this study, we make use of an observational constraint on aerosol lifetimes provided by radionuclide measurements and investigate the causes of differences within a set of global models. During the Fukushima Dai-Ichi nuclear power plant accident of March 2011, the radioactive isotopes cesium-137 (137Cs) and xenon-133 (133Xe) were released in large quantities. Cesium attached to particles in the ambient air, approximately according to their available aerosol surface area. 137Cs size distribution measurements taken close to the power plant suggested that accumulation-mode (AM) sulfate aerosols were the main carriers of cesium. Hence, 137Cs can be used as a proxy tracer for the AM sulfate aerosol's fate in the atmosphere. In contrast, the noble gas 133Xe behaves almost like a passive transport tracer. Global surface measurements of the two radioactive isotopes taken over several months after the release allow the derivation of a lifetime of the carrier aerosol. We compare this to the lifetimes simulated by 19 different atmospheric transport models initialized with identical emissions of 137Cs that were assigned to an aerosol tracer with each model's default properties of AM sulfate, and 133Xe emissions that were assigned to a passive tracer. We investigate to what extent the modelled sulfate tracer can reproduce the measurements, especially with respect to the observed loss of aerosol mass with time. Modelled 137Cs and 133Xe concentrations sampled at the same location and times as station measurements allow a direct comparison between measured and modelled aerosol lifetime. The e-folding lifetime τe, calculated from station measurement data taken between 2 and 9 weeks after the start of the emissions, is 14.3 days (95 % confidence interval 13.1–15.7 days). The equivalent modelled τe lifetimes have a large spread, varying between 4.8 and 26.7 days with a model median of 9.4 ± 2.3 days, indicating too fast a removal in most models. Because sufficient measurement data were only available from about 2 weeks after the release, the estimated lifetimes apply to aerosols that have undergone long-range transport, i.e. not for freshly emitted aerosol. However, modelled instantaneous lifetimes show that the initial removal in the first 2 weeks was quicker (lifetimes between 1 and 5 days) due to the emissions occurring at low altitudes and co-location of the fresh plume with strong precipitation. Deviations between measured and modelled aerosol lifetimes are largest for the northernmost stations and at later time periods, suggesting that models do not transport enough of the aerosol towards the Arctic. The models underestimate passive tracer (133Xe) concentrations in the Arctic as well but to a smaller extent than for the aerosol (137Cs) tracer. This indicates that in addition to too fast an aerosol removal in the models, errors in simulated atmospheric transport towards the Arctic in most models also contribute to the underestimation of the Arctic aerosol concentrations.

Abstract Acyl coenzyme A binding protein (ACBP), also known as diazepam binding inhibitor (DBI) is a multifunctional protein with an intracellular action (as ACBP), as well as with an extracellular role (as DBI). The plasma levels of soluble ACBP/DBI are elevated in human obesity and reduced in anorexia nervosa. Accumulating evidence indicates that genetic or antibody-mediated neutralization of ACBP/DBI has anorexigenic effects, thus inhibiting food intake and inducing lipo-catabolic reactions in mice. A number of anorexiants have been withdrawn from clinical development because of their side effects including an increase in depression and suicide. For this reason, we investigated the psychiatric impact of ACBP/DBI in mouse models and patient cohorts. Intravenously (i.v.) injected ACBP/DBI protein conserved its orexigenic function when the protein was mutated to abolish acyl coenzyme A binding, but lost its appetite-stimulatory effect in mice bearing a mutation in the γ2 subunit of the γ-aminobutyric acid (GABA) A receptor (GABAAR). ACBP/DBI neutralization by intraperitoneal (i.p.) injection of a specific mAb blunted excessive food intake in starved and leptin-deficient mice, but not in ghrelin-treated animals. Neither i.v. nor i.p. injected anti-ACBP/DBI antibody affected the behavior of mice in the dark–light box and open-field test. In contrast, ACBP/DBI increased immobility in the forced swim test, while anti-ACBP/DBI antibody counteracted this sign of depression. In patients diagnosed with therapy-resistant bipolar disorder or schizophrenia, ACBP/DBI similarly correlated with body mass index (BMI), not with the psychiatric diagnosis. Patients with high levels of ACBP/DBI were at risk of dyslipidemia and this effect was independent from BMI, as indicated by multivariate analysis. In summary, it appears that ACBP/DBI neutralization has no negative impact on mood and that human depression is not associated with alterations in ACBP/DBI concentrations.

AbstractAcyl-coenzyme-A-binding protein (ACBP), also known as a diazepam-binding inhibitor (DBI), is a potent stimulator of appetite and lipogenesis. Bioinformatic analyses combined with systematic screens revealed that peroxisome proliferator-activated receptor gamma (PPARγ) is the transcription factor that best explains the ACBP/DBI upregulation in metabolically active organs including the liver and adipose tissue. The PPARγ agonist rosiglitazone-induced ACBP/DBI upregulation, as well as weight gain, that could be prevented by knockout of Acbp/Dbi in mice. Moreover, liver-specific knockdown of Pparg prevented the high-fat diet (HFD)-induced upregulation of circulating ACBP/DBI levels and reduced body weight gain. Conversely, knockout of Acbp/Dbi prevented the HFD-induced upregulation of PPARγ. Notably, a single amino acid substitution (F77I) in the γ2 subunit of gamma-aminobutyric acid A receptor (GABAAR), which abolishes ACBP/DBI binding to this receptor, prevented the HFD-induced weight gain, as well as the HFD-induced upregulation of ACBP/DBI, GABAAR γ2, and PPARγ. Based on these results, we postulate the existence of an obesogenic feedforward loop relying on ACBP/DBI, GABAAR, and PPARγ. Interruption of this vicious cycle, at any level, indistinguishably mitigates HFD-induced weight gain, hepatosteatosis, and hyperglycemia.

AbstractIn mice, the plasma concentrations of the appetite-stimulatory and autophagy-inhibitory factor acyl-coenzyme A binding protein (ACBP, also called diazepam-binding inhibitor, DBI) acutely increase in response to starvation, but also do so upon chronic overnutrition leading to obesity. Here, we show that knockout of Acbp/Dbi in adipose tissue is sufficient to prevent high-fat diet-induced weight gain in mice. We investigated ACBP/DBI plasma concentrations in several patient cohorts to discover a similar dual pattern of regulation. In relatively healthy subjects, ACBP/DBI concentrations independently correlated with body mass index (BMI) and age. The association between ACBP/DBI and BMI was lost in subjects that underwent major weight gain in the subsequent 3–9 years, as well as in advanced cancer patients. Voluntary fasting, undernutrition in the context of advanced cancer, as well as chemotherapy were associated with an increase in circulating ACBP/DBI levels. Altogether, these results support the conclusion that ACBP/DBI may play an important role in body mass homeostasis as well as in its failure.

Acyl-coenzyme A (CoA)–binding protein (ACBP), also known as diazepam-binding inhibitor (DBI), is an extracellular feedback regulator of autophagy. Here, we report that injection of a monoclonal antibody neutralizing ACBP/DBI (α-DBI) protects the murine liver against ischemia/reperfusion damage, intoxication by acetaminophen and concanavalin A, and nonalcoholic steatohepatitis caused by methionine/choline-deficient diet as well as against liver fibrosis induced by bile duct ligation or carbon tetrachloride. α-DBI downregulated proinflammatory and profibrotic genes and upregulated antioxidant defenses and fatty acid oxidation in the liver. The hepatoprotective effects of α-DBI were mimicked by the induction of ACBP/DBI-specific autoantibodies, an inducible Acbp/Dbi knockout or a constitutive Gabrg2 F77I mutation that abolishes ACBP/DBI binding to the GABA A receptor. Liver-protective α-DBI effects were lost when autophagy was pharmacologically blocked or genetically inhibited by knockout of Atg4b . Of note, α-DBI also reduced myocardium infarction and lung fibrosis, supporting the contention that it mediates broad organ-protective effects against multiple insults.

AbstractRecently, we reported that, in mice, hunger causes the autophagy-dependent release of a protein called “acyl-CoA-binding protein” or “diazepam binding inhibitor” (ACBP/DBI) from cells, resulting in an increase in plasma ACBP concentrations. Administration of extra ACBP is orexigenic and obesogenic, while its neutralization is anorexigenic in mice, suggesting that ACBP is a major stimulator of appetite and lipo-anabolism. Accordingly, obese persons have higher circulating ACBP levels than lean individuals, and anorexia nervosa is associated with subnormal ACBP plasma concentrations. Here, we investigated whether ACBP might play a phylogenetically conserved role in appetite stimulation. We found that extracellular ACBP favors sporulation in Saccharomyces cerevisiae, knowing that sporulation is a strategy for yeast to seek new food sources. Moreover, in the nematode Caenorhabditis elegans, ACBP increased the ingestion of bacteria as well as the frequency pharyngeal pumping. These observations indicate that ACBP has a phylogenetically ancient role as a ‘hunger factor’ that favors food intake.

AbstractThe diffuse nature of Glioblastoma (GBM) tumors poses a challenge to current therapeutic options. We have previously shown that Acyl-CoA Binding Protein (ACBP, also known as DBI) regulates lipid metabolism in GBM cells, favoring fatty acid oxidation (FAO). Here we show that ACBP downregulation results in wide transcriptional changes affecting invasion-related genes. In vivo experiments using patient-derived xenografts combined with in vitro models demonstrated that ACBP sustains GBM invasion via binding to fatty acyl-CoAs. Blocking FAO mimics ACBPKD-induced immobility, a cellular phenotype that can be rescued by increasing FAO rates. Further investigation into ACBP-downstream pathways served to identify Integrin beta-1, a gene downregulated upon inhibition of either ACBP expression or FAO rates, as a mediator for ACBP’s role in GBM invasion. Altogether, our findings highlight a role for FAO in GBM invasion and reveal ACBP as a therapeutic vulnerability to stall FAO and subsequent cell invasion in GBM tumors.

Abstract Background Cholangiocarcinoma (CCA) is an aggressive disease with poor prognosis. A molecular classification based on mutational, methylation and transcriptomic features could allow identifying tailored therapies to improve CCA patient outcome. Proteomic remains partially unexplored; here, we analyzed the proteomic profile of five intrahepatic cholangiocarcinoma (ICC) derived from Italian patients undergone surgery and one normal bile duct cell line. Methods Proteome profile was investigated by using 2D electrophoresis followed by Mass Spectrometry (MS). To validate proteomic data, the expression of four overexpressed proteins (CAT, SOD, PRDX6, DBI/ACBP) was evaluated by immunohistochemistry in an independent cohort of formalin fixed, paraffin-embedded (FFPE) ICC tissues. We also compared proteomic data with those obtained by transcriptomic profile evaluated by microarray analysis of the same tissues. Results We identified 19 differentially expressed protein spots, which were further characterized by MS; 13 of them were up- and 6 were down-regulated in ICC. These proteins are mainly involved in redox processes (CAT, SODM, PRDX2, PRDX6), in metabolism (ACBP, ACY1, UCRI, FTCD, HCMS2), and cell structure and organization (TUB2, ACTB). CAT is overexpressed in 86% of patients, PRDX6 in 73%, SODM in 100%, and DBI/ACBP in 81% compared to normal adjacent tissues. A concordance of 50% between proteomic and transcriptomic data was observed. Conclusions This study pointed out that the impairment of the metabolic and antioxidant systems, with a subsequent accumulation of free radicals, might be a key step in CCA development and progression.

Abstract Type-2 diabetes is characterized by glycosuria, hyperglycemia, glucose intolerance, hyperinsulinemia, and insulin resistance. One or several among these alterations are also found after starvation, ketogenic diet, and pharmacological treatment with rapamycin or antibody-mediated neutralization of the obesogenic factor ACBP/DBI. Thus, a variety of metabolic interventions that improve metabolic health can induce a transient state of “pseudo-diabetes”.

ABSTRACT Influenza virus infections continue to pose a major public health threat worldwide associated with seasonal epidemics and sporadic pandemics. Vaccination is considered the first line of defense against influenza. Live attenuated influenza virus vaccines (LAIVs) may provide superior responses compared to inactivated vaccines because the former can better elicit a combination of humoral and cellular responses by mimicking a natural infection. Unfortunately, during the 2013–2014, 2014–2015, and 2015–2016 seasons, concerns emerged about the effectiveness of the only LAIV approved in the United States that prevented the Advisory Committee on Immunization Practices (ACIP) from recommending its use. Such drawbacks open up the opportunity for alternative LAIV strategies that could overcome such concerns. Previously, we developed a combined strategy of temperature-sensitive mutations in the PB2 and PB1 segments and an epitope tag in the C terminus of PB1 that effectively attenuates influenza A viruses of avian and mammalian origin. More recently, we adopted a similar strategy for influenza B viruses. The resulting attenuated (att) influenza A and B viruses were safe, immunogenic, and protective against lethal influenza virus challenge in a variety of animal models. In this report, we provide evidence of the potential use of our att strategy in a quadrivalent LAIV (QIV) formulation carrying H3N2 and H1N1 influenza A virus subtype viruses and two antigenic lineages of influenza B viruses. In naive DBA/2J mice, two doses of the QIV elicited hemagglutination inhibition (HI) responses with HI titers of ≥40 and effectively protected against lethal challenge with prototypical pandemic H1N1 influenza A and influenza B virus strains. IMPORTANCE Seasonal influenza viruses infect 1 billion people worldwide and are associated with ∼500,000 deaths annually. In addition, the never-ending emergence of zoonotic influenza viruses associated with lethal human infections and of pandemic concern calls for the development of better vaccines and/or vaccination strategies against influenza virus. Regardless of the strategy, novel influenza virus vaccines must aim at providing protection against both seasonal influenza A and B viruses. In this study, we tested an alternative quadrivalent live attenuated influenza virus vaccine (QIV) formulation whose individual components have been previously shown to provide protection. We demonstrate in proof-of principle studies in mice that the QIV provides effective protection against lethal challenge with either influenza A or B virus.

Diabetes Mellitus has been becoming a disease of the century, and disease incidence is still rising worldwide. It causes many serious complications, especially in the eye, heart, kidneys, brain, and vascular system, such as diabetic nephropathy, diabetic retinopathy, liver fa­ilure, etc. Moreover, the process of controlling this disease is complicated. Meanwhile, the antidiabetic drugs on the market are facing some problems with a wide range of adverse reactions. Therefore, finding new drugs to treat diabetes has always been a topic that many researchers are interested in, especially drugs derived from nature like microorganisms and medicinal plants. This review is to provide knowledge concerning the effects of α-glucosidase inhibitors, which are oral antidiabetic drugs commonly used for diabetes mellitus type 2. Besides, we show readers the variety of active ingredients originating from nature, particularly the secondary metabolites of Aspergillus spp., which have many applications in the chemical and medicinal industry. Keywords: Diabetes, α-glucosidase inhibitors, Aspergillus. References [1] W. H. Organization, Classification of Diabetes Mellitus, https://www.who.int/westernpacific/health-topics/diabetes (accessed on: May 11th, 2021).[2] J. Thrasher, Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies, Am J Cardiol, Vol. 120, No. 1, 2017, pp. S4-S16, https://doi.org/10.1016/j.amjcard.2017.05.009.[3] W. Hakamata, M. Kurihara, H. Okuda, T. Nishio, T. Oku, Design and Screening Strategies for Alpha-glucosidase Inhibitors Based on Enzymological Information, Curr Top Med Chem, Vol. 9, No. 1, 2009, pp. 3-12, https://doi.org/10.2174/156802609787354306.[4] US, Patent Version Number: US4062950A, Amino Sugar Derivatives, https://patents.google.com/patent/US4062950A/en(accessed on: May 11th, 2021).[5] A. S. Dabhi, N. R. Bhatt, M. J. Shah, Voglibose: an Alpha- glucosidase Inhibitor, J Clin Diagn Res, Vol. 7, No. 12, 2013, pp. 3023-3027, https://doi.org/10.7860/JCDR/2013/6373.3838.[6] P. Durruty, M. Sanzana, L. Sanhueza, Pathogenesis of Type 2 Diabetes Mellitus, Type 2 Diabetes - from Pathophysiology to Modern Management, Intechopen, United Kingdom, 2019, pp. 1-18.[7] L. N. Khue, T. H. Dang, T. H. Quang, N. T. Khue et al., Guidelines for Diagnosis and Treatment of Diabetes Type 2, Ministry of Health, Vietnam, 2021 (in Vietnamese).[8] M. Okuyama, W. Saburi, H. Mori, A. Kimura, Alpha-Glucosidases and Alpha-1,4-Glucan Lyases: Structures, Functions, and Physiological Actions, Cell Mol Life Sci, Vol. 73, 2016, pp. 2727-2751, https://doi.org/10.1007/s00018-016-2247-5.[9] V. L. Yip, S. G. Withers, Nature's Many Mechanisms for The Degradation of Oligosaccharides, Org Biomol Chem, Vol. 19, No. 2, 2004, pp. 2707-2713, https://doi.org/10.1039/B408880H.[10] B. Henrissat, A. Bairoch, New Families in The Classification of Glycosyl Hydrolases Based on Amino Acid Sequence Similarities, Biochem J, Vol. 293, No. 3, 1993, pp. 781-788, https://doi.org/10.1042/bj2930781.[11] B. Henrissat, A Classification of Glycosyl Hydrolases Based on Amino Acid Sequence Similarities, Biochem J, Vol. 280, No. 2, 1991, pp. 309-316, https://doi.org/10.1042/bj2800309.[12] R. Gupta, P. Gigras, H. Mohapatra, V. K. Goswami, B. Chauhan, Microbial A-amylases: A Biotechnological Perspective, Process Biochemistry, Vol. 38, No. 11, 2003, pp. 1599-1616, https://doi.org/10.1016/s0032-9592(03)00053-0.[13] C. V. D. Maarel, B. V. D. Veen, J. C .M. Uitdehaag, H. Leemhuis, L. Dijkhuizen, Properties and Applications of Starch-Converting Enzymes of The A-Amylase Family, Journal of Biotechnology, Vol. 94, No. 2, 2002, pp. 137-155, https://doi.org/10.1016/s0168-1656(01)00407-2.[14] N. R. Kim, D. W. Jeong, D. S. Ko, J. H. Shim, Characterization of Novel Thermophilic Alpha-Glucosidase from Bifidobacterium Longum, Int J Biol Macromol, Vol. 99, 2017, pp. 594-599, https://doi.org/10.1016/j.ijbiomac.2017.03.009.[15] D. R. Rose, M. M. Chaudet, K. Jones, Structural Studies of The Intestinal Alpha-Glucosidases, Maltase-glucoamylase and Sucrase-isomaltase, J Pediatr Gastroenterol Nutr, Vol. 66, No. 3, 2018, pp. S11-S13, https://doi.org/10.1097/MPG.0000000000001953.[16] L. Ren, X. Qin, X. Cao, L. Wang, F. Bai, G. Bai, Y. Shen, Structural Insight into Substrate Specificity of Human Intestinal Maltase-Glucoamylase, Protein Cell, Vol. 2, 2011, pp. 827-836, https://doi.org/10.1007/s13238-011-1105-3.[17] L. Sim, C. Willemsma, S. Mohan, H. Y. Naim, B. M. Pinto, D. R. Rose, Structural Basis for Substrate Selectivity in Human Maltase-Glucoamylase and Sucrase-Isomaltase N-Terminal Domains, J Biol Chem, Vol. 285, No. 23, 2010, pp. 17763-17770, https://doi.org/10.1074/jbc.M109.078980.[18] K. Jones, L. Sim, S. Mohan, J. Kumarasamy,H. Liu, S. Avery, H. Y. Naim, R. Q. Calvillo, B. L. Nichols, B. M. Pinto, D. R. Rose, Mapping The Intestinal Alpha-Glucogenic Enzyme Specificities of Starch Digesting Mal se-Glucoamylase and Sucrase-Isomaltase, Bioorg Med Chem, Vol. 19, 2011, pp. 3929-3934, https://doi.org/10.1016/j.bmc.2011.05.033.[19] P. T. T. Chau, P. T. Nghia, Enzyme and Application, Education Publisher, Vietnam, 2009.[20] Researchgate, Food Protein-Derived Bioactive Peptides in Management of Type 2 Diabetes - Scientific Figure, https://www.researchgate.net/figure/Mechanism-of-action-of-alpha-glucosidase-inhibitors_fig2_279991207 (accessed on: May 10th, 2021).[21] Z. Liu, S. Ma, Recent Advances in Synthetic Alpha-Glucosidase Inhibitors, Chem Med Chem, Vol. 12, No. 11, 2017, pp. 819-829, https://doi.org/10.1002/cmdc.201700216.[22] A. Lee, P. Patrick, J. Wishart, M. Horowitz, J. E. Morley, The Effects of Miglitol on Glucagon-Like Peptide-1 Secretion And Appetite Sensations in Obese Type 2 Diabetics, Diabetes Obes Metab, Vol. 4, No. 5, 2002, pp. 329-335, https://doi.org/10.1046/j.14631326.2002.00219.x.[23] I. Takei, K. Miyamoto, O. Funae, N. Ohashi, S. Meguro, M. Tokui, T. Saruta, Secretion of GIP in Responders to Acarbose in Obese Type 2 (NIDDM) Patients, Journal of Diabetes and Its Complications, Vol. 15, No. 5, 2001, pp. 245-249, https://doi.org/10.1016/s1056-8727(01)00148-9.[24] X. Bian, X. Fan, C. Ke, Y. Luan, G. Zhao, A. Zeng, Synthesis and Alpha-Glucosidase Inhibitory Activity Evaluation of N-Substituted Aminomethyl-Beta-D-Glucopyranosides, Bioorg Med Chem, Vol. 21, No. 17, 2013, pp. 5442-5450, https://doi.org/10.1016/j.bmc.2013.06.002.[25] J. B. Yang, J. Y. Tian, Z. Dai, F. Ye, S. C. Ma, A. G. Wang, α-Glucosidase Inhibitors Extracted from The Roots of Polygonum Multiflorum Thunb, Fitoterapia, Vol. 117, 2017, pp. 65-70, https://doi.org/10.1016/j.fitote.2016.11.009.[26] Z. Yin, W. Zhang, F. Feng, Y. Zhang, W. Kang, α-Glucosidase Inhibitors Isolated from Medicinal Plants, Food Science and Human Wellness, Vol. 3, No.3-4, 2014, pp. 136-174, https://doi.org/10.1016/j.fshw.2014.11.003.[27] P. Qiu, Z. Liu, Y. Chen, R. Cai, G. Chen, Z. She, Secondary Metabolites with Alpha-Glucosidase Inhibitory Activity from The Mangrove Fungus Mycosphaerella sp. SYSU-DZG01, Mar Drugs, Vol. 17, No. 8, 2019, pp. 483-508, https://doi.org/10.3390/md17080483.[28] S. Munasaroh, S. R. Tamat, R. T. Dewi, Isolation and Identification of α-Glucosidase Inhibitor from Aspergillus Terreus F38, Indonesian Journal of Pharmacy, Vol. 29, No. 2, 2018, pp. 74-79, https://doi.org/10.14499/indonesianjpharm29iss2pp74.[29] R. T. Dewi, A. Suparman, H. Mulyani, P. D. N. Lotulung, Identification of A New Compound as α-Glucosidase Inhibitor from Aspergillus Aculeatus, Annales Bogorienses, Vol. 20, No. 1, 2016, pp. 19-23, https://doi.org/10.14203/ann. bogor .2016.v20.n1.19-23.[30] R. T. Dewi, S. Tachibana, A. Darmawan, Effect on α-Glucosidase Inhibition and Antioxidant Activities of Butyrolactone Derivatives from Aspergillus Terreus MC751, Medicinal Chemistry Research, Vol. 23, 2014, pp. 454-460, https://doi.org/10.1007/s00044-013-0659-4.[31] M. G. Kang, S. H. Yi, J. S. Lee, Production and Characterization of A New Alpha-Glucosidase Inhibitory Peptide from Aspergillus Oryzae N159-1, Mycobiology, Vol. 41, No. 3, 2013, pp. 149-154, https://doi.org/10.5941/MYCO.2013.41.3.149.[32] S. Onose, R. Ikeda, K. Nakagawa, T. Kimura, K. Yamagishi, O. Higuchi, T. Miyazawa, Production of The Alpha-Glycosidase Inhibitor 1-Deoxynojirimycin from Bacillus Species, Food Chem, Vol. 138, No. 1, 2013, pp. 516-523, https://doi.org/10.1016/j.foodchem.2012.11.012.[33] Y. P. Zhu, K. Yamaki, T. Yoshihashi, M. Ohnishi Kameyama, X. T. Li, Y. Q. Cheng, Y. Mori, L. T. Li, Purification and Identification of 1-Deoxynojirimycin (DNJ) in Okara Fermented by Bacillus Subtilis B2 from Chinese Traditional Food (Meitaoza), J Agric Food Chem, Vol. 58,No. 7, 2010, pp. 4097-4103, https://doi.org/10.1021/jf9032377.[34] A. Tabussum, N. Riaz, M. Saleem, M. Ashraf, M. Ahmad, U. Alam, B. Jabeen, A. Malik, A. Jabbar, α-Glucosidase Inhibitory Constituents from Chrozophora Plicata, Phytochemistry Letters, Vol. 6, No. 4. 2013, pp. 614-619, https://doi.org/10.1016/j.phytol.2013.08.005.[35] M. Yagi, T. Kouno, Y. Aoyagi, H. Murai, The Structure of Moranoline, A Piperidine Alkaloid from Morus Species, Journal of The Agricultural Chemical Society of Japan, Vol. 50, No. 11, 1976, pp. 571-572, https://doi.org/10.1271/nogeikagaku1924.50.11_571.[36] M. Hemker, A. Stratmann, K. Goeke, W. Schroder, J. Lenz, W. Piepersberg, H. Pape, Identification, Cloning, Expression, and Characterization of The Extracellular Acarbose-Modifying Glycosyltransferase, AcbD, from Actinoplanes Sp. Strain SE50, J Bacteriol, Vol. 183, No. 15, 2001, pp. 4484-4492, https://doi.org/10.1128/JB.183. 15.4484-4492.2001.[37] E. Truscheit, I. Hillebrand, B. Junge, L. Müller, W. Puls, D. Schmidt, Microbial α-Glucosidase Inhibitors: Chemistry, Biochemistry, and Therapeutic Potential, Presented at Drug Concentration Monitoring Microbial alpha-Glucosidase Inhibitors Plasminogen Activators, Springer-Verlag, Berlin, 1988.[38] Y. Kameda, N. Asano, M. Yoshikawa, M. Takeuchi, T. Yamaguchi, K. Matsui, S. Horii, H. Fukase, Valiolamine, A New Alpha-Glucosidase Inhibiting Aminocyclitol Produced by Streptomyces Hygroscopicus, J Antibiot (Tokyo), Vol. 37, No. 11, 1984, pp. 1301-1307, https://doi.org/10.7164/antibiotics.37.1301.[39] D. T. Tuyen, V. V. Hanh, V. T. T. Hang, D. K. Trinh, D. T. Quyen, Extraction and Purification of DNJ (1-Deoxynojirimycin) Inhibiting α-Glucosidase from B. Subtilis VN9 Strain Isolated from Vietnam, National Biotechnology Conference, 2013.[40] D. T. Tuyen, Optimization and Purification of α-Glucosidase Inhibitor from Bacillus Subtilis YT20 Isolated in Vietnam, Vietnam Journal of Science and Technology, Vol. 59, No. 2, 2021, pp. 179-188, https://doi.org/10.15625/2525-2518/ 59/2/14928.[41] S. E. Baker, J. W. Bennett, An Overview of the Genus Aspergillus, Aspergillus: Molecular Biology and Genomics, The Aspergilli, Taylor & Francis, United Kingdom, 2008, pp. 3-13.[42] H. C. Gugnani, Ecology and Taxonomy of Pathogenic Aspergilli, Front Biosci, Vol. 8, No. 6, 2003, pp. s346- s357, https://doi.org/10.2741/1002.[43] C. G. Shaw, The Genus Aspergillus, Science, Vol. 150, No. 3697, 1965, pp. 736-737, https://doi.org/10.1126/science.150.3697.736-a.[44] M. T. Hedayati, A. C. Pasqualotto, P. A. Warn, P. Bowyer, D. W. Denning, Aspergillus Flavus: Human Pathogen, Allergen and Mycotoxin Producer, Microbiology, Vol. 153, No. 6, 2007, pp. 1677-1692, https://doi.org/10.1099/mic.0.2007/007641-0.[45] T. R. Dagenais, N. P. Keller, Pathogenesis of Aspergillus Fumigatus in Invasive Aspergillosis, Clin Microbiol Rev, Vol. 22, No. 3, 2009, pp. 447-465, https://doi.org/10.1128/CMR.00055-08.[46] S. Amaike, N. P. Keller, Aspergillus Flavus, Annu Rev Phytopathol, Vol. 49, 2011, pp. 107-133, https://doi.org/10.1146/annurev-phyto-072910-095221.[47] J. Houbraken, R. P. De Vries, R. A. Samson, Modern Taxonomy of Biotechnologically Important Aspergillus and Penicillium Species, Adv Appl Microbiol, Vol. 86, 2014, pp. 199-249, https://doi.org/10.1016/B978-0-12-800262-9.00004-4.[48] E. Ichishima, Development of Enzyme Technology for Aspergillus Oryzae, A. Sojae, and A. Luchuensis, The National Microorganisms of Japan, Biosci Biotechnol Biochem, Vol. 80, No. 9, 2016, pp. 1681-1692, https://doi.org/10.1080/09168451.2016.1177445.[49] E. Schuster, N. Dunn-Coleman, J. C. Frisvad, P. W. Van Dijck, on The Safety of Aspergillus Niger-A Review, Appl Microbiol Biotechnol, Vol. 59, No. 4-5, 2002, pp. 426-435, https://doi.org/10.1007/s00253-002-1032-6.[50] J. H. Yu, N. Keller, Regulation of Secondary Metabolism in Filamentous Fungi, Annu Rev Phytopathol, Vol. 43, 2005, pp. 437-458, https://doi.org/10.1146/annurev.phyto.43.040204.140214.[51] J. F. Sanchez, A. D. Somoza, N. P. Keller, C. C. Wang, Advances in Aspergillus Secondary Metabolite Research in The Post-Genomic Era, Nat Prod Rep, Vol. 29, No. 3, 2012, pp. 351-371, https://doi.org/10.1039/c2np00084a.[52] J. W. Bennett, M. Klich, Mycotoxins, Clin Microbiol Rev, Vol. 16, 2003, pp. 497-516, https://doi.org/10.1128/cmr.16.3.497-516.2003.[53] Q. Zhou, J. K. Liao, Statins and cardiovascular Diseases: from Cholesterol Lowering to Pleiotropy, Curr Pharm Des, Vol. 15, No. 5, 2009, pp. 467-478, https://doi.org/10.2174/138161209787315684.[54] A. W. Alberts, Discovery, Biochemistry and Biology of Lovastatin, Am J Cardiol, Vol. 62, No. 15, 1988, pp. 10J-15J, https://doi.org/10.1016/0002-9149(88)90002-1.[55] H. Tomoda, Y. K. Kim, H. Nishida, R. Masuma, S. Omura, Pyripyropenes, Novel Inhibitors of Acyl-Coa: Cholesterol Acyltransferase Produced by Aspergillus Fumigatu- Production, Isolation, and Biological Properties, J Antibiot (Tokyo), Vol. 47, No. 2, 1994, pp. 148-153, https://doi.org/10.7164/antibiotics.47.148.[56] F. Pelaez, Biological Activities of Fungal Metabolites, Marcel Dekker, United Stated of America, 2004.[57] E. L. Dulaney, Penicillin Production by The Aspergillus Nidulans Group, Mycologia, Vol. 39, No. 5, 2018, pp. 582-586, https://doi.org/10.1080/00275514.1947.12017637.[58] T. T. Bladt, J. C. Frisvad, P. B. Knudsen, T. O. Larsen, Anticancer and Antifungal Compounds from Aspergillus, Penicillium and Other Filamentous Fungi, Molecules, Vol. 18, No. 9, 2013, pp. 11338-11376, https://doi.org/10.3390/molecules180911338.[59] Y. Wu, Y. Chen, X. Huang, Y. Pan, Z. Liu, T. Yan, W. Cao, Z. She, alpha-Glucosidase Inhibitors: Diphenyl Ethers and Phenolic Bisabolane Sesquiterpenoids from The Mangrove Endophytic Fungus Aspergillus Flavus QQSG-3, Mar Drugs, Vol. 16, No. 9, 2018, pp. 307-316, https://doi.org/10.3390/md16090307.